Effect of Entecavir, Tenofovir Disoproxil Fumarate, and Tenofovir Alafenamideantiviral Therapy on Renal Function in Chronic Hepatitis B Patients: A Real-World Retrospective Study
In real-life experience, ETV, TDF, and TAF therapy may not be associated with eGFR changes in NUC-experienced CHB patients without baseline renal impairment.
Authors
- Li Yu (ORCID: https://orcid.org/0000-0003-2131-7018)
- Yawei Li (ORCID: https://orcid.org/0000-0001-5933-8194)
- Ying Gao (ORCID: https://orcid.org/0000-0002-9156-9483)
Institutions
- Hubei University of Medicine (CN)
- Shanxi Medical University (CN)
- Shaanxi Provincial People's Hospital (CN)
- Taihe Hospital (CN)
- Shanxi Provincial People’s Hospital (CN)
Publication Details
- Journal
- International Journal of General Medicine
- Published
- 2025-02-01
- DOI
- https://doi.org/10.2147/ijgm.s497550
- Citations
- 1
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.35